Since the abnormal cholesterol metabolism is regarded as involved in AD development, in patients with AD of late-onset type and in healthy elderly controls not taking any lipid-lowering drugs and with no cerebrovascular lesions in neuroimaging, the relationship between the plasma lipoprotein profile and LDL density and between PON1 promoter genotypes was assessed. Here, PON1 is linked to Alzheimer disease.